- Home
- CTSO vs ONDS Comparison
CTSO vs ONDS Comparison
Compare CTSO & ONDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- ONDS
- Stock Information
- Founded
- CTSO 1997
- ONDS 2014
- Country
- CTSO United States
- ONDS United States
- Employees
- CTSO N/A
- ONDS N/A
- Industry
- CTSO Medical/Dental Instruments
- ONDS Telecommunications Equipment
- Sector
- CTSO Health Care
- ONDS Telecommunications
- Exchange
- CTSO Nasdaq
- ONDS Nasdaq
- Market Cap
- CTSO 52.6M
- ONDS 326.8M
- IPO Year
- CTSO N/A
- ONDS N/A
- Fundamental
- Price
- CTSO $1.07
- ONDS $2.13
- Analyst Decision
- CTSO Buy
- ONDS Strong Buy
- Analyst Count
- CTSO 2
- ONDS 2
- Target Price
- CTSO $5.50
- ONDS $3.25
- AVG Volume (30 Days)
- CTSO 137.0K
- ONDS 21.0M
- Earning Date
- CTSO 08-12-2025
- ONDS 08-13-2025
- Dividend Yield
- CTSO N/A
- ONDS N/A
- EPS Growth
- CTSO N/A
- ONDS N/A
- EPS
- CTSO N/A
- ONDS N/A
- Revenue
- CTSO $35,332,238.00
- ONDS $10,815,867.00
- Revenue This Year
- CTSO $18.34
- ONDS $243.35
- Revenue Next Year
- CTSO $19.82
- ONDS $118.81
- P/E Ratio
- CTSO N/A
- ONDS N/A
- Revenue Growth
- CTSO 15.37
- ONDS N/A
- 52 Week Low
- CTSO $0.71
- ONDS $0.54
- 52 Week High
- CTSO $1.61
- ONDS $3.40
- Technical
- Relative Strength Index (RSI)
- CTSO 52.96
- ONDS 60.24
- Support Level
- CTSO $0.93
- ONDS $1.71
- Resistance Level
- CTSO $1.16
- ONDS $1.93
- Average True Range (ATR)
- CTSO 0.11
- ONDS 0.20
- MACD
- CTSO -0.02
- ONDS -0.02
- Stochastic Oscillator
- CTSO 45.77
- ONDS 51.08
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.